Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors.

Ramsay, Euan C; Anantha, Malathi; Zastre, Jason; Meijs, Marieke; Zonderhuis, Jet; Strutt, Dita; Webb, Murray S; Waterhouse, Dawn; Bally, Marcel B

Ramsay, Euan C; Anantha, Malathi; Zastre, Jason; Meijs, Marieke; Zonderhuis, Jet; Strutt, Dita; Webb, Murray S; Waterhouse, Dawn; Bally, Marcel B.

Affiliation

Ramsay EC; Department of Advanced Therapeutics, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 1L3.

Clin Cancer Res ; 14(4): 1208-17, 2008 Feb 15.

Article in En | MEDLINE | ID: mdl-18281556

Subject(s)

Antineoplastic Agents/administration & dosage; Antineoplastic Agents/pharmacokinetics; Camptothecin/analogs & derivatives; Neoplasms, Experimental/drug therapy; Animals; Camptothecin/administration & dosage; Camptothecin/pharmacokinetics; Female; Humans; Irinotecan; Liposomes; Mice; Mice, Inbred BALB C; Xenograft Model Antitumor Assays

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Camptothecin / Neoplasms, Experimental / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google